7L3N

SARS-CoV 2 Spike Protein bound to LY-CoV555

7L3N の概要

• エントリーDOI: 10.2210/pdb7l3n/pdb
• EMDBエントリー: 23156
• 分子名称: Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain, ... (5 entities in total)
• 機能のキーワード: glycoprotein, viral protein-immune system complex, viral protein/immune system
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV); 詳細
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 475782.79

構造登録者

Goldsmith, J.A.,McLellan, J.S. (登録日: 2020-12-18, 公開日: 2021-02-03)

• 主引用文献: Jones, B.E.,Brown-Augsburger, P.L.,Corbett, K.S.,Westendorf, K.,Davies, J.,Cujec, T.P.,Wiethoff, C.M.,Blackbourne, J.L.,Heinz, B.A.,Foster, D.,Higgs, R.E.,Balasubramaniam, D.,Wang, L.,Bidshahri, R.,Kraft, L.,Hwang, Y.,Zentelis, S.,Jepson, K.R.,Goya, R.,Smith, M.A.,Collins, D.W.,Hinshaw, S.J.,Tycho, S.A.,Pellacani, D.,Xiang, P.,Muthuraman, K.,Sobhanifar, S.,Piper, M.H.,Triana, F.J.,Hendle, J.,Pustilnik, A.,Adams, A.C.,Berens, S.J.,Baric, R.S.,Martinez, D.R.,Cross, R.W.,Geisbert, T.W.,Borisevich, V.,Abiona, O.,Belli, H.M.,de Vries, M.,Mohamed, A.,Dittmann, M.,Samanovic, M.,Mulligan, M.J.,Goldsmith, J.A.,Hsieh, C.L.,Johnson, N.V.,Wrapp, D.,McLellan, J.S.,Barnhart, B.C.,Graham, B.S.,Mascola, J.R.,Hansen, C.L.,Falconer, E.; LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection.; Biorxiv, 2020; PubMed: 33024963; DOI: 10.1101/2020.09.30.318972

実験手法

ELECTRON MICROSCOPY (3.27 Å)